Literature DB >> 19615471

Cardiovascular adaptations, fluid shifts, and countermeasures related to space flight.

Alan R Hargens1, Sara Richardson.   

Abstract

Significant progress has been made related to understanding cardiovascular adaptations to microgravity and development of countermeasures to improve crew re-adaptation to gravity. The primary ongoing issues are orthostatic intolerance after flight, reduced exercise capacity, the effect of vascular-smooth muscle loss on other physiologic systems, development of efficient and low-cost countermeasures to counteract these losses, and an understanding of fluid shift mechanisms. Previous animal studies of cardiovascular adaptations offer evidence that prolonged microgravity remodels walls of blood vessels, which in turn, is important for deconditioning of the cardiovascular system and other functions of the body. Over the past 10 years, our studies have documented that treadmill exercise within lower body negative pressure counteracts most physiologic decrements with bed rest in both women and men. Future studies should improve hardware and protocols to protect crew members during prolonged missions. Finally, it is proposed that transcapillary fluid shifts in microgravity may be related to the loss of tissue weight and external compression of blood vessels.

Entities:  

Mesh:

Year:  2009        PMID: 19615471     DOI: 10.1016/j.resp.2009.07.005

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  48 in total

1.  Anterior-posterior transcranial ultrasound to measure cranial oscillations.

Authors:  John H K Liu; John E Lynch; Armando Rosales-Velderrain; Douglas G Chang; Robert N Weinreb; Alan R Hargens
Journal:  Aviat Space Environ Med       Date:  2013-09

Review 2.  Adaptation to microgravity, deconditioning, and countermeasures.

Authors:  Kunihiko Tanaka; Naoki Nishimura; Yasuaki Kawai
Journal:  J Physiol Sci       Date:  2016-12-20       Impact factor: 2.781

Review 3.  Space physiology IV: mathematical modeling of the cardiovascular system in space exploration.

Authors:  M Keith Sharp; Jerry Joseph Batzel; Jean-Pierre Montani
Journal:  Eur J Appl Physiol       Date:  2013-03-29       Impact factor: 3.078

Review 4.  Region-specific vascular remodeling and its prevention by artificial gravity in weightless environment.

Authors:  Li-Fan Zhang
Journal:  Eur J Appl Physiol       Date:  2013-03-24       Impact factor: 3.078

5.  Psychoneuroendocrine alterations during 5 days of head-down tilt bed rest and artificial gravity interventions.

Authors:  A Choukèr; B Feuerecker; S Matzel; I Kaufmann; C Strewe; M Hoerl; G Schelling; M Feuerecker
Journal:  Eur J Appl Physiol       Date:  2013-04-12       Impact factor: 3.078

6.  Comparison of cardiovascular and biomechanical parameters of supine lower body negative pressure and upright lower body positive pressure to simulate activity in 1/6 G and 3/8 G.

Authors:  Thomas Schlabs; Armando Rosales-Velderrain; Heidi Ruckstuhl; Alexander C Stahn; Alan R Hargens
Journal:  J Appl Physiol (1985)       Date:  2013-05-02

7.  Effects of exercise countermeasure on myocardial contractility measured by 4D speckle tracking during a 21-day head-down bed rest.

Authors:  D Greaves; P Arbeille; L Guillon; K Zuj; E G Caiani
Journal:  Eur J Appl Physiol       Date:  2019-09-17       Impact factor: 3.078

Review 8.  Skeletal changes during and after spaceflight.

Authors:  Laurence Vico; Alan Hargens
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

Review 9.  Space physiology VI: exercise, artificial gravity, and countermeasure development for prolonged space flight.

Authors:  Alan R Hargens; Roshmi Bhattacharya; Suzanne M Schneider
Journal:  Eur J Appl Physiol       Date:  2012-10-19       Impact factor: 3.078

10.  Regional specific adaptation of the endothelial glycocalyx dimension in tail-suspended rats.

Authors:  Hongyan Kang; Lianwen Sun; Yunfei Huang; Zhenze Wang; Ping Zhao; Yubo Fan; Xiaoyan Deng
Journal:  Pflugers Arch       Date:  2014-07-05       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.